Oncolytics Biotech
Kirk Look is currently serving as the CFO and Controller at Oncolytics Biotech Inc. since April 2003. Prior to this, Kirk worked at Ernst & Young LLP from 1995 to 2003, holding the title of Manager. Kirk holds a Bachelor of Commerce in Accounting and Economics from the University of Calgary, and recently completed a Master of Science in Jurisprudence in Law from Seton Hall University School of Law in 2022.
Oncolytics Biotech
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called REOLYSIN® for the treatment of solid tumors and hematological malignancies.